ライフサイエンスコーパス: improved prognosis

1 ity of BSCB in diabetic SCI rats, leading to improved prognosis.

2 ensity after a breast cancer diagnosis to an improved prognosis.

3 tiretroviral therapy (ART) has significantly improved prognosis.

4 sponse to neoadjuvant chemoradiation have an improved prognosis.

5 etween TGFBR3, GPC1, and SDC3 expression and improved prognosis.

6 ansient and not necessarily indicative of an improved prognosis.

7 ver-kidney transplantation offer promise for improved prognosis.

8 nt-related mortality have contributed to the improved prognosis.

9 do respond to treatment with a significantly improved prognosis.

10 t and recurrent setting, and have an overall improved prognosis.

11 the parenchyma, identifies patients with an improved prognosis.

12 inoma, it is associated with a significantly improved prognosis.

13 patients would accept this care only for an improved prognosis.

14 alopathy is critical for early treatment and improved prognosis.

15 from Study IV and discussed the findings on improved prognosis.

16 c cardiomyopathy and diabetes mellitus, with improved prognosis.

17 nti-GM2 antibodies have been associated with improved prognosis.

18 of sporadic colorectal carcinomas that have improved prognosis.

19 agnitude of the DCH response correlated with improved prognosis.

20 otherapy and female sex were associated with improved prognosis.

21 ith RER-positive tumors have a significantly improved prognosis.

22 that patients with RER-positive CRC have an improved prognosis.

23 e to identify promising interventions and an improved prognosis.

24 States citizens, since therapy now offers an improved prognosis.

25 Milan criteria (MC) in 1996 has dramatically improved prognosis after liver transplantation (LT) in p

26 point for every complete 100 cells per mm3) improved prognosis; age of 50 years or older (2 points)

27 iltration of solid tumors is associated with improved prognosis and favorable responses to immunother

28 l aspect of treating many cancers and offers improved prognosis and prolonged survival in many cases;

29 2-positive breast cancer are associated with improved prognosis and response to therapy.

30 of chromosomes 1p and 19q is associated with improved prognosis and responsiveness to therapy in pati

31 scriptionally altered loci as biomarkers for improved prognosis and therapy.

32 and regulation will hopefully translate into improved prognosis and treatment for patients suffering

33 ing the release or effect of PNE may lead to improved prognosis and/or a reduction in morbidity.

34 llomavirus-associated tumors seem to have an improved prognosis, and may respond differently to treat

35 ral nifedipine challenge is predictive of an improved prognosis, and potential clinical efficacy in P

36 approaches that may hold hope for obtaining improved prognosis are presented.

37 ng induction chemotherapy, appear to have an improved prognosis as compared with reports using standa

38 ave an increased prevalence of ESRD, but the improved prognosis associated with remission is so signi

39 HPF group was independently associated with improved prognosis at 5 years (P =.002) in regression mo

40 manner is crucial for better management and improved prognosis, but is currently unavailable.

41 lorectal carcinomas has been associated with improved prognosis, but its clinical significance in spo

42 hat BRCA2-related EOC was associated with an improved prognosis, but the effect of BRCA1 remains uncl

43 ated HNSCCs have a distinct risk profile and improved prognosis compared to cancers associated with t

44 stage, HPV-driven OPSCCs are associated with improved prognosis compared with HPV-negative disease.

45 RECENT FINDINGS: Improved prognosis compared with systemic chemotherapy a

46 ositive disease who received trastuzumab had improved prognosis compared with women with HER2/neu-neg

47 en TGFBR2 and EMT that may contribute to the improved prognosis consistently observed in colon cancer

48 normal acute myeloid leukemia and to confer improved prognosis, especially in patients without a con

49 mmunity to tumor antigens is associated with improved prognosis for many cancers.

50 contain erlotinib for KRAS mut+ patients and improved prognosis for mesenchymal tumors, better biomar

51 The improved prognosis for patients with HIV-associated lymp

52 correlates with both response to therapy and improved prognosis for patients with oligodendrogliomas.

53 et strategies that may ultimately lead to an improved prognosis for the cancer patient.(1)

54 ly increased risk of Hodgkin's lymphoma, and improved prognosis for those who develop HIV-associated

55 with studies showing that MI correlates with improved prognosis in colon and gastric cancers.

56 indings indicate that instability confers an improved prognosis in colorectal cancer and, despite the

57 ality, and regression of ECG LVH may predict improved prognosis in hypertensive patients.

58 se agents can facilitate early diagnosis and improved prognosis in patients with bladder cancer.

59 The overall survival highlights an improved prognosis in patients with RCC in the era of ta

60 lacement therapy (HRT) is associated with an improved prognosis in women with advanced heart failure

61 nd whether these changes are associated with improved prognosis independent of blood pressure reducti

62 Improved prognosis is associated with spontaneous liver

63 e influence of airway transport phenotype on improved prognosis is not known.

64 f axillary lymph node-positive patients with improved prognosis may be identified using a lower (< 3

65 relevant biomarkers for early diagnosis and improved prognosis of alcoholism and identify future pha

66 Imatinib therapy has significantly improved prognosis of chronic myeloid leukemia.

67 nsitory period of euphoria engendered by the improved prognosis of pneumococcal pneumonia resulting f

68 ciated with a significantly reduced risk and improved prognosis of psoriasis and psoriatic arthritis,

69 sion of favorable alleles does not guarantee improved prognosis or viral control.

70 t patients with node-positive disease had an improved prognosis over the two decades studied.

71 cer, with a favorable disease profile and an improved prognosis, particularly in women.

72 tion of PCP have decreased its frequency and improved prognosis, PCP continues to be seen in both HIV

73 crol immediately after HAART initiation also improved prognosis (relative hazard = 0.34, 95% confiden

74 nt atrial fibrillation is associated with an improved prognosis remains to be established.

75 ich inflammatory profiles (if any) relate to improved prognosis.Streptococcus pneumonia is a common h

76 th RER-positive tumors were found to have an improved prognosis: the 5-year survival probability for

77 agnosis and appears to be associated with an improved prognosis; this finding suggests that surgery s

78 Improved prognosis was seen with increasing current alco

79 particular, solid-predominant tumors had an improved prognosis with adjuvant radiotherapy.

80 The association of improved prognosis with plasmacytic infiltrates has been

81 ventricle hearts have resulted in remarkably improved prognosis, with the expectation of continued im

82 ry lymph node-positive breast cancer with an improved prognosis would be clinically useful.